Safety of C5-targeted therapies in generalized myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials with long-term extension data

Mukesh Kumar Sharma

Open source

DOI
10.17605/osf.io/tnzqr
Published
2026
Container
Not recorded
Publisher
OSF Registries
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.17605/osf.io/tnzqr,
  title = {Safety of C5-targeted therapies in generalized myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials with long-term extension data},
  author = {Mukesh Kumar Sharma},
  year = {2026},
  doi = {10.17605/osf.io/tnzqr},
  url = {https://doi.org/10.17605/osf.io/tnzqr}
}

RIS

TY  - JOUR
TI  - Safety of C5-targeted therapies in generalized myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials with long-term extension data
AU  - Mukesh Kumar Sharma
PY  - 2026
DO  - 10.17605/osf.io/tnzqr
UR  - https://doi.org/10.17605/osf.io/tnzqr
ER  - 

APA

Sharma, M. K. (2026). Safety of C5-targeted therapies in generalized myasthenia gravis: a systematic review and meta-analysis of randomized controlled trials with long-term extension data. https://doi.org/10.17605/osf.io/tnzqr

Source records